Product Reports Resources Pricing Login Book a demo

Shenzhen Sailu Medical Technology

Biotech & Life Sciences · China · Founded 2020

Explores spatial biology with innovated sequencing technology MoreLess

Salus Biomed is a pioneering company in the field of life sciences, specializing in advanced DNA sequencing and spatial omics research tools. The company serves a diverse range of clients, including academic researchers, clinical laboratories, and biotechnology firms. Operating in the rapidly growing genomics and spatial biology markets, Salus Biomed leverages its proprietary Next-Generation Sequencing (NGS) platform and super-resolution imaging techniques to deliver high-performing DNA sequencers and ultra-high resolution spatial omics tools. These products are designed to support both clinical sequencing applications and fundamental spatial omics studies, offering flexible and rapid data output options ranging from 10 to 240G per run. The business model is centered around the sale of these innovative instruments and associated consumables, as well as providing specialized research services. Revenue is generated through direct sales, service contracts, and collaborative research agreements. Salus Biomed's commitment to innovation and collaboration is evident in its multidisciplinary team of experts in engineering, chemistry, molecular biology, and bioinformatics, all working together to unlock new possibilities in life science.

Keywords: DNA sequencing, spatial omics, genomics, NGS platform, super-resolution imaging, clinical applications, research tools, biotechnology, bioinformatics, life sciences.

Company overview

Shenzhen Sailu Medical Technology company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
China
Employees
4
Open positions
None listed
Dealroom signal
80.9
client focusb2bsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorSpinoutsectorBiotech and PharmasectorDT and LSsectorscience-based

Valuation & funding

Shenzhen Sailu Medical Technology funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Oct 2025 $6.9M $289M Amoy Diagnostic
SERIES AEquity / VC May 2025 Shenzhen Capital Group · Shanghai Fosun Pharmaceutical
SERIES AEquity / VC Dec 2023 $28M $110M Bangqin Capital · Qianhai FOF · Suzhou Dunhang Investment Management · Shenzhen Capital Group
EARLY VCEquity / VC Oct 2022 $14M $55M GreatWall Fund · Qilu Investment · Longping Biotechnology
SEEDEquity / VC Apr 2022 $0 Undisclosed
ANGELEquity / VC Oct 2021 ZhenFund
SPINOUTOther financing Jan 2020 North Carolina State University
Showing 7 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 4
2025 4
2024 4
2023 2
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Shenzhen Sailu Medical Technology website traffic

Latest recorded traffic for Shenzhen Sailu Medical Technology is 430 monthly website visits, up 65.4% over the last three months. Shenzhen Sailu Medical Technology's team grew 0% over the past year.

Latest monthly visits430 3-month web change+65.4% 1-year team growth0%
Monthly website visits26 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Shenzhen Sailu Medical Technology compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Shenzhen Sailu Medical Technology's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on Shenzhen Sailu Medical Technology's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 11 investors entered at this stage
GreatWall Fund
Qilu Investment
Longping Biotechnology
Bangqin Capital
Qianhai FOF
Suzhou Dunhang Investment Management
Shenzhen Capital Group
BioTrack Capital
Yazhou Bay Venture Capital
Shanghai Fosun Pharmaceutical
Amoy Diagnostic
Other known 1 additional known investor
North Carolina State University

Global footprint

Where Shenzhen Sailu Medical Technology has talent and traffic

Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

In the news

Latest news about Shenzhen Sailu Medical Technology

Recent press, funding announcements, and product moves mentioning Shenzhen Sailu Medical Technology — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Shenzhen Sailu Medical Technology

An AI-synthesized read of the highest-engagement posts about Shenzhen Sailu Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shenzhen Sailu Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.